CoChat

Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease

Kai, Jun, Yang, Xiang, Wang, Zhimin, Wang, Feixia, Jia, Yan, Wang, Shijun, Tan, Shanzhong, Chen, Anping, Shao, Jiangjuan, Zhang, Feng, Zhang, Zili, Zheng, Shizhong · 2020 · Free Radical Biology and Medicine
Cited by 101

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND It is well acknowledged that alcoholic liver disease (ALD) is widely prevalent all over the world, characterized by aberrant lipid deposition and excessive oxidative stress in hepatocytes. Recently, pyroptosis, a new type of programmed cell death, has been found in ALD, which provides new ideas for the treatment of ALD. METHODS Male ICR mice were treated with the Lieber-De-Carli diet (Dyets) or isocaloric maltodextrin solution for 8 weeks, and binge alcohol model was also used for ALD. Blood and liver were taken to evaluate the efficacy of Oroxylin A. The level of factors related to hepatocyte pyroptosis were measured via Western blot analyses, Immunofluorescence analyses and Quantitative reverse transcriptase in vitro. RESULT Our study found that oroxylin A suppressed hepatocyte pyroptosis through a NLRP3 inflammasome dependent-canonical caspase-1 pathway. Results illuminated that oroxylin A inhibited NLRP3 inflammasome activation by reducing ROS accumulation. Furthermore, oroxylin A upregulated mitofusin 2 (Mfn2) to resist lipid deposition and mitochondria-derived ROS overproduction. As an upstream mediator of Mfn2, peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), a major regulator of mitochondria, was found to promote transcription of Mfn2 under oroxylin A treatment. CONCLUSION Our research revealed that oroxylin A could alleviate ALD via PGC-1α/Mfn2 signaling mediated canonical pyroptosis pathway resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.freeradbiomed.2020.03.031

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 101

Metadata

Authors
Kai, J., Yang, X., Wang, Z., Wang, F., Jia, Y., Wang, S., Tan, S., Chen, A., Shao, J., Zhang, F., Zhang, Z., & Zheng, S.
Venue
Free Radical Biology and Medicine
Publisher
Elsevier BV
Published
2020-06
Volume
153
Pages
89-102
ISSN
0891-5849 (ISSN-L)
OpenAlex
W3015499709
Cited by
101
References
12
FWCI
7.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease. https://app.cochat.ai/papers/10.1016/j.freeradbiomed.2020.03.031
The paper
Kai, J., Yang, X., Wang, Z., Wang, F., Jia, Y., Wang, S., Tan, S., Chen, A., Shao, J., Zhang, F., Zhang, Z., & Zheng, S. (2020). Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease. Free Radical Biology and Medicine. https://doi.org/10.1016/j.freeradbiomed.2020.03.031

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.